替加环素联合头孢哌酮舒巴坦治疗多重耐药菌致重症肺炎的效果

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of Tigecycline combined with Cefoperazone Sulbactam in the treatment of severe pneumonia caused by multi-drug resistant bacteria. Methods A total of patients with severe pneumonia caused by multi-drug resistant bacteria treated in the Affiliated Huai′an NO.1 People′s Hospital of Nanjing Medical University from January 2017 to February 2020 were selected as research objects. According to the random number table method,they were divided into experimental group and control group, with 40 cases in each group. The experimental group took Tigecycline combined with Cefoperazone Sulbactam treatment, the control group was treated with Cefoperazone Sulbactam. The treatment efficiency, oxygen metabolism indexes, and adverse reactions of the two groups were compared. Results The total effective rate of experimental group after treatment was higher than that of control group, and the difference was statistically significant (P<0.05). After treatment, the indexes of oxygen saturation (SaO2), oxygen supply (DO2),and partial pressure of oxygen (PaO2) in the two groups were higher than those before treatment, and oxygen consumption(VO2) was lower than that before treatment, the differences were statistically significant (P<0.05). The indexes of SaO2,DO2, PaO2 in the experimental group were higher than those in the control group, and VO2 was lower than in the control group, the differences were statistically significant (P<0.05). There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion Patients with severe pneumonia caused by multi-drug resistant bacteria are treated with Tigecycline combined with Cefoperazone Sulbactam, which has a positive effect on improving the state of oxygen metabolism. The treatment effect is significant, and the safety of medication is high.

Key words： Severe pneumonia caused by multi-drug resistant bacteria Tigecycline Cefoperazone Sulbactam Combination therapy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZUO Tong-kun
	TANG Qing
	HUI Liang-liang
	ZHANG Xiang-cheng
	SHANG Fu-tai

Cite this article:

ZUO Tong-kun,TANG Qing,HUI Liang-liang, et al. Effect of Tigecycline combined with Cefoperazone Sulbactam in the treatment of severe pneumonia caused by multi-drug resistant bacteria[J]. 中国当代医药, 2021, 28(3): 80-82转94.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I3/80

[1]	罗文明.纤支镜灌洗治疗多重耐药菌感染所致重症肺炎的临床症状改善分析[J].糖尿病天地，2019，16（1）：127.
[2]	宋攀，黄垂国，李云龙，等.抗菌药物在外科的不合理应用及对策[J].中华医院感染学杂志，2017，27（3）：717-720.
[3]	郑嘉堂，孔玉侠，费秀文，等.普通感冒治疗中抗菌药物使用现况与影响因素[J].中华全科医师杂志，2018，17（11）：941.
[4]	刘亚，杨艳兵.头孢哌酮钠舒巴坦钠联合替加环素对老年重症肺炎患者细菌清除率的影响[J].中国合理用药探索，2019，16（9）：71-73，76.
[5]	郑晓梦，叶云，张幸国.替加环素联合舒巴坦制剂治疗鲍曼不动杆菌感染的meta 分析[J].中国现代应用药学，2019，36（15）：1932-1940.
[6]	田爱庆.替加环素联合头孢哌酮/舒巴坦治疗泛耐药鲍曼不动杆菌老年重症肺炎的临床疗效分析[J].吉林医学，2019，40（7）：1495-1496.
[7]	朱晓飞，苏秀平，王丁超.替加环素治疗危重症老年呼吸机相关性肺炎患者的疗效观察[J].哈尔滨医药，2019，39（2）：101-102.
[8]	冯永海，郭涛，郭迪，等.替加环素联合头孢哌酮/舒巴坦对泛耐药鲍曼不动杆菌感染肺炎患者APACHEⅡ评分及细菌清除率的影响[J].黑龙江医药科学，2018，41（6）：97-98.
[9]	张妍，苏晓蕾，赵睿，等.替加环素治疗多重耐药菌所致重症肺炎的效果及对氧代谢状态的影响[J].中国医药导报，2018，15（27）：106-109.
[10]	张立梅，曹薇薇，毛媛媛，等.替加环素联合头孢哌酮/舒巴坦对多重耐药鲍曼不动杆菌引起血流感染患者的疗效分析[J].河北医药，2018，40（18）：2730-2733.
[11]	刘雪健，胡静雯，廖明喻，等.细菌性重症肺炎病原学特征及药物敏感性分析[J].青岛大学医学院学报，2018，54（4）：461-464.
[12]	邱泳波.替加环素、舒巴坦、头孢哌酮治疗老年泛耐药鲍曼不动杆菌重症肺炎的效果观察[J].海峡药学，2018，30（8）：250-251.
[13]	陈利红，郭利涛，张蕾，等.替加环素治疗鲍曼不动杆菌引起的重症肺炎对其血清ADM、ET-1 水平的影响[J].贵州医药，2018，42（6）：692-694.
[14]	崔娜，杨丽珍，于占彪，等.替加环素与亚胺培南西司他丁治疗医院获得性肺炎疗效比较[J].中国药业，2018，27（8）：62-64.
[15]	郑丽娜，李云霞，吴静.抗菌药物不良反应分析[J].中华医院感染学杂志，2016，26（10）：2378-2380.
[16]	李本根，李霞，娄金波，等.泌尿系统结石合并感染患者尿液标本病原菌分布及耐药性分析[J].中华医院感染学杂志，2018，28（21）：3282-3285.